AAAAAA

   
Results: 1-16 |
Results: 16
Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis
Authors: Trollfors, B Lagergard, T Taranger, J Bergfors, E Schneerson, R Robbins, JB
Citation: B. Trollfors et al., Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis, CL DIAG LAB, 8(5), 2001, pp. 1015-1017
Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine
Authors: Taranger, J Trollfors, B Bergfors, E Knutsson, N Lagergard, T Schneerson, R Robbins, JB
Citation: J. Taranger et al., Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine, PEDIATRICS, 108(6), 2001, pp. NIL_98-NIL_103
The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children
Authors: Lin, FYC Ho, VA Khiem, HB Trach, DD Bay, PV Thanh, TC Kossaczka, Z Bryla, DA Shiloach, J Robbins, JB Schneerson, R Szu, SC Lanh, MN Hunt, S Trinh, L Kaufman, JB
Citation: Fyc. Lin et al., The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children, N ENG J MED, 344(17), 2001, pp. 1263-1269
Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo
Authors: Schwebach, JR Casadevall, A Schneerson, R Dai, ZD Wang, XJ Robbins, JB Glatman-Freedman, A
Citation: Jr. Schwebach et al., Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo, INFEC IMMUN, 69(9), 2001, pp. 5671-5678
Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel
Authors: Passwell, JH Harlev, E Ashkenazi, S Chu, CY Miron, D Ramon, R Farzan, N Shiloach, J Bryla, DA Majadly, F Roberson, R Robbins, JB Schneerson, R
Citation: Jh. Passwell et al., Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel, INFEC IMMUN, 69(3), 2001, pp. 1351-1357
A rebuttal: epidemic and endemic meningococcal. meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine
Authors: Robbins, JB Schneerson, R Gotschlich, EC
Citation: Jb. Robbins et al., A rebuttal: epidemic and endemic meningococcal. meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine, PEDIAT INF, 19(10), 2000, pp. 945-953
Are only antibody levels involved in the protection against pertussis in acellular pertussis vaccine recipients? Reply
Authors: Trollfors, B Schneerson, R Robbins, JB
Citation: B. Trollfors et al., Are only antibody levels involved in the protection against pertussis in acellular pertussis vaccine recipients? Reply, J INFEC DIS, 182(5), 2000, pp. 1576-1577
Correlation between pertussis toxin IgG antibodies in postvaccination seraand subsequent protection against pertussis
Authors: Taranger, J Trollfors, B Lagergard, T Sundh, V Bryla, DA Schneerson, R Robbins, JB
Citation: J. Taranger et al., Correlation between pertussis toxin IgG antibodies in postvaccination seraand subsequent protection against pertussis, J INFEC DIS, 181(3), 2000, pp. 1010-1013
Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: Studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in mice
Authors: Pavliakova, D Moncrief, JS Lyerly, DM Schiffman, G Bryla, DA Robbins, JB Schneerson, R
Citation: D. Pavliakova et al., Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: Studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in mice, INFEC IMMUN, 68(4), 2000, pp. 2161-2166
Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis
Authors: Trollfors, B Taranger, J Lagergard, T Sundh, V Bryla, DA Schneerson, R Robbins, JB
Citation: B. Trollfors et al., Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis, CLIN INF D, 28(3), 1999, pp. 552-559
Similarities between the pathogenesis of and immunity to diphtheria and pertussis: The complex nature of serum antitoxin-induced immunity to these two diseases
Authors: Schneerson, R
Citation: R. Schneerson, Similarities between the pathogenesis of and immunity to diphtheria and pertussis: The complex nature of serum antitoxin-induced immunity to these two diseases, CLIN INF D, 28, 1999, pp. S136-S139
Bacterial polysaccharide-protein conjugate vaccines
Authors: Robbins, JB Schneerson, R Szu, SC Pozsgay, V
Citation: Jb. Robbins et al., Bacterial polysaccharide-protein conjugate vaccines, PUR A CHEM, 71(5), 1999, pp. 745-754
Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1
Authors: Pozsgay, V Chu, CY Pannell, L Wolfe, J Robbins, JB Schneerson, R
Citation: V. Pozsgay et al., Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1, P NAS US, 96(9), 1999, pp. 5194-5197
Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children
Authors: Ashkenazi, S Passwell, JH Harlev, E Miron, D Dagan, R Farzan, N Ramon, R Majadly, F Bryla, DA Karpas, AB Robbins, JB Schneerson, R
Citation: S. Ashkenazi et al., Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children, J INFEC DIS, 179(6), 1999, pp. 1565-1568
Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2-to 4-year-old children in Vietnam
Authors: Kossaczka, Z Lin, FYC Ho, VA Thuy, NTT Van Bay, P Thanh, TC Khiem, HB Trach, DD Karpas, A Hunt, S Bryla, DA Schneerson, R Robbins, JB Szu, SC
Citation: Z. Kossaczka et al., Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2-to 4-year-old children in Vietnam, INFEC IMMUN, 67(11), 1999, pp. 5806-5810
Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice
Authors: Pavliakova, D Chu, CY Bystricky, S Tolson, NW Shiloach, J Kaufman, JB Bryla, DA Robbins, JB Schneerson, R
Citation: D. Pavliakova et al., Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice, INFEC IMMUN, 67(10), 1999, pp. 5526-5529
Risultati: 1-16 |